v3.26.1
Acquisitions - Summary of Fair Value of Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Thousands
Jul. 21, 2025
Apr. 01, 2025
Jun. 30, 2026
Dec. 31, 2025
Liabilities assumed:        
Goodwill     $ 239,050 $ 239,517
Evergreen Theragnostics        
Assets acquired:        
Cash and cash equivalents   $ 8,065    
Accounts receivable, other   2,758    
Prepaid expenses and other current assets   459    
Property, plant and equipment, net   16,711    
Intangibles   215,000    
Deferred tax assets   18,112    
Other long-term assets   1,424    
Total identifiable assets acquired   262,529    
Liabilities assumed:        
Accounts payable   (1,964)    
Accrued expenses and other current liabilities   (754)    
Deferred tax liabilities   (55,718)    
Other long-term liabilities   (848)    
Total liabilities assumed   (59,284)    
Net assets acquired   203,245    
Purchase consideration   319,466    
Goodwill   $ 116,221    
Lantheus Biosciences Ltd        
Assets acquired:        
Cash and cash equivalents $ 46,193      
Accounts receivable, other 25,123      
Inventory 1,125      
Prepaid expenses and other current assets 1,974      
Property, plant and equipment, net 4,979      
Intangibles 394,000      
Deferred tax assets 15,993      
Other long-term assets 11,506      
Total identifiable assets acquired 500,893      
Liabilities assumed:        
Accounts payable (5,715)      
Accrued expenses and other current liabilities (25,964)      
Deferred tax liabilities (72,570)      
Other long-term liabilities (79,904)      
Total liabilities assumed (184,153)      
Net assets acquired 316,740      
Purchase consideration 379,614      
Goodwill $ 62,874